KospicyKorean filings in English
Filings / Samsung Biologics

Insider Ownership Report

Samsung Biologics · 임원ㆍ주요주주특정증권등소유상황보고서

4KOSPI · 207940 Filed 2026-11-20Korean original on DART

English form view 85% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on Specified Securities Owned by Officers and Major Shareholders

6.1

삼성바이오로직스

20261118

Report on Specified Securities Owned by Officers and Major Shareholders

To: Securities and Futures Commission
To: Korea Exchange
Reporting obligation date:2026-11-18
Report reference date:2026-11-18
※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission.
Reporting person:Samsung C&T Corporation

1. Issuer information

Company NameSamsung Biologics Co., Ltd.
Entity typeKOSPI-listed companyCompany code207940
Total Shares Issued48,560,951

2. Reporting Person Information

Report TypeChangeReporting person typeDomestic corporation
Name (Entity Name)KoreanSamsung C&T CorporationChinese characters (English)三星物産(株)(Samsung C&TCorporation)
Date of Birth or Business Registration No., etc.202-81-45975
Address (Head Office) [Town/District Level Only]서울특별시 강동구 상일로
Relationship to IssuerOfficer (Registered or Not)-Position-
Appointment Date-Resignation Date-
Major Shareholder10%+ shareholder
Business contact and person in chargeAffiliated companySamsung C&T CorporationDepartmentIR금융팀
Position프로Phone Number02-214**
Name신동아Fax number02-202**
Email address**[email protected]

3. Ownership of specified securities

a. Specified securities owned and ownership ratio

Report reference dateSpecified SecuritiesShare Certificates
Number of Specified Securities (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026-10-1920,715,16844.0119,932,35043.06
This Report2026-11-1820,715,16842.6620,715,16842.66
Change0-1.35782,818-0.4

b. Ownership of specified securities by type

Details of Specified Securities
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsParticipating BondsExchangeable bondsDepositary receiptsOtherTotal
Number of sharesRatio (%)
20,715,168-------20,715,16842.66
ABCDEFGH
I
Total Shares Issued (J)Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I)Ownership ratio (%)
Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100Shareholding Ratio (A / J) × 100
48,560,951-42.6642.66

※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying

c. Change details

Reason for ReportChange Date*Type of Specified SecuritiesShares Owned (shares)Acquisition/Disposal Unit Price (KRW)**RemarksTrading plan report date
Before ChangeChangeAfter Change
기타(-)2026-11-18Instruments representing preemptive rights782,818-782,8180-유상신주취득에 따른신주인수권증서 효력 소멸-
유상신주취득(+)2026-11-18Common Stock19,932,350782,81820,715,1681,174,000구주주 청약에 따른유상신주취득-
Total20,715,168020,715,168--

※ 상기 세부변동내역 중 "취득/처분단가(원)"는 발행회사의 유상증자 신주 발행가액(1,174,000원)임* 증권시장에서 주식등을 매매한 경우에는 그 계약결제일

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities